Roche Korea said it appointed Ezat Azem as the new general manager, effective from Wednesday. 

According to the company, Ezat Azem brings over 27 years of experience within the Roche Group, having joined the company's Israel branch in 1997.

His extensive background includes significant roles in various countries, including Romania and Slovenia, where he led marketing divisions and played a pivotal role in launching and growing key pharmaceutical products.

From July 2019 until his recent appointment to the Korean offshoot, Azem served as the General Manager of Roche Greece, overseeing the launch and reimbursement of eight new drugs, greatly enhancing patient access to innovative medications.

Azem graduated from Hebrew University, where he studied Medical Sciences. He later obtained a Master of Business Administration (MBA) from Tel Aviv University and completed executive education programs at INSEAD (Institut Européen d'Administration des Affaires) in France and London Business School (LBS) in the U.K.

"I am thrilled to begin working in Korea, a country known for its excellent medical environment," Azem said. "Drawing on my diverse experiences, I am committed to contributing to the health of Korean patients through Roche's innovative medicines and precision therapies."